Home / Mesothelioma.net / Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients

Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients

Malignant mesothelioma is a rare and deadly form of cancer most frequently diagnosed decades after its victims are exposed to...

from Mesothelioma.net https://ift.tt/TAWncjz
via IFTTT
Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients Reviewed by Unknown on January 23, 2024 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.